Herba Siegesbeckiae subfraction HS-C protects against myocardial I/R injury

Announcing a new publication for Acta Materia Medica journal. Herba Siegesbeckiae (HS) has been traditionally used for managing cardio- and cerebro-vascular diseases.

Genomic Testing in Endometrial Cancer

Genomic testing matters in endometrial cancer both for prognostication and therapeutic selection, but there’s work to do in making sure it reaches all women. “It

August 2, 2024

Newly identified small molecule can suppress growth of breast and ovarian cancers in animal models

Researchers at Baylor College of Medicine have identified a small molecule named 5D4 that can suppress the growth of breast and ovarian cancers in animal

October 26, 2023

Real World CAR T-Cell Therapy Outcomes ‘Favorable’ in Relapsed/Refractory Myeloma

Real-world outcomes of patients with relapsed/refractory multiple myeloma treated with the chimeric antigen receptor (CAR) T-cell therapy ciltacabtagene autoleucel (cilta-cel, Carvykti) showed “favorable” efficacy results,

October 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.